Monomer-Coated Very Small Superparamagnetic Iron Oxide Particles as Contrast Medium for Magnetic Resonance Imaging
- 1 April 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 37 (4) , 167-177
- https://doi.org/10.1097/00004424-200204000-00002
Abstract
Wagner S, Schnorr J, Pilgrimm H, et al. Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization. Invest Radiol 2002;37:167–177. rationale and objectives. Preclinical in-vivo characterization of a newly developed MR contrast medium consisting of very small superparamagnetic iron oxide particles (VSOP) coated with citrate (VSOP-C184). methods. VSOP-C184 (core diameter: 4 nm; total diameter: 8.6 nm; relaxivities in water at 0.94 T (T1) 20.1 and (T2) 37.1 l/[mmol*sec]) was investigated to determine its pharmacokinetics, efficacy, acute single dose toxicity, repeated dose toxicity, and genotoxicity. results. The plasma elimination half-life at 0.045 mmol Fe/kg was 21.3 ± 5.5 minutes in rats and 36.1 ± 4.2 minutes in pigs, resulting in a T1-relaxation time of plasma of < 100 milliseconds for 30 minutes in pigs. The particles are mainly cleared via the phagocytosing system of the liver. MR angiography at a dose of 0.045 mmol Fe/kg shows an excellent depiction of the thoracic and abdominal vasculature in rats and of the coronary arteries in pigs. The LD50 in mice is > 17.9 mmol Fe/kg. A good tolerance and safety profile was found. conclusions. The experiments indicate, that VSOP-C184 may be a well tolerated and safe contrast medium for MR imaging that can be effectively used for MR angiography including visualization of the coronary arteries.Keywords
This publication has 39 references indexed in Scilit:
- ‘NC100150’, a preparation of iron oxide nanoparticles ideal for positive-contrast MR angiographyMagnetic Resonance Materials in Physics, Biology and Medicine, 1999
- Pulmonary MR Angiography with Ultrasmall Superparamagnetic Iron Oxide Particles as a Blood Pool Agent and a Navigator Echo for Respiratory Gating: Pilot StudyRadiology, 1999
- MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation.American Journal of Roentgenology, 1999
- Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiographyJournal of Magnetic Resonance Imaging, 1999
- MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agentJournal of Magnetic Resonance Imaging, 1997
- Intravenous MR lymphography with superparamagnetic iron oxide particles: experimental studies in rats and rabbitsEuropean Radiology, 1995
- Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.Radiology, 1990
- Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging.Radiology, 1988
- Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver.Radiology, 1988
- Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system.Radiology, 1987